aap Implantate AG (ETR:AAQ1)
Germany · Delayed Price · Currency is EUR 1.660
-0.020 (-1.19%)
Sep 16, 2026, 1:17 PM CET
aap Implantate AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 12.21 | 12.49 | 12.2 | 11.48 | 11.52 | 12.17 |
Other Revenue | 0 | - | - | - | - | - |
| 12.21 | 12.49 | 12.2 | 11.48 | 11.52 | 12.17 | |
Revenue Growth | 1.82% | 2.33% | 6.32% | -0.33% | -5.34% | 30.45% |
Cost of Revenue | 1.39 | 2.27 | 2.18 | 2.13 | 1.45 | 1.75 |
Gross Profit | 10.81 | 10.21 | 10.03 | 9.35 | 10.07 | 10.42 |
Selling, General & Admin | 6.77 | 6.42 | 6.3 | 6.97 | 6.88 | 6.72 |
Other Operating Expenses | 4.63 | 4.54 | 4.53 | 4.43 | 5.56 | 5.01 |
Operating Expenses | 13.59 | 12.93 | 12.81 | 15.38 | 14.11 | 13.57 |
Operating Income | -2.77 | -2.71 | -2.78 | -6.03 | -4.04 | -3.15 |
Interest Expense | -0.15 | -0.07 | -0.17 | -0.17 | -0.37 | -0.5 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 |
Currency Exchange Gain (Loss) | 0.32 | 0.32 | -0.35 | 0.03 | 0.13 | 0.22 |
Other Non Operating Income (Expenses) | -0.11 | -0.11 | 0.06 | 0.14 | 0.06 | 0.07 |
EBT Excluding Unusual Items | -2.7 | -2.56 | -3.23 | -6.02 | -4.21 | -3.34 |
Merger & Restructuring Charges | - | - | - | -0.5 | - | -0.1 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.07 |
Legal Settlements | - | - | - | - | - | -0.2 |
Other Unusual Items | -0.04 | -0.04 | - | -1 | 0.6 | 0.7 |
Pretax Income | -2.75 | -2.6 | -3.23 | -7.52 | -3.61 | -2.86 |
Income Tax Expense | -0.02 | -0.01 | 0.41 | 0.45 | -1.05 | -0.34 |
Earnings From Continuing Operations | -2.73 | -2.59 | -3.63 | -7.96 | -2.56 | -2.52 |
Net Income | -2.73 | -2.59 | -3.63 | -7.96 | -2.56 | -2.52 |
Net Income to Common | -2.73 | -2.59 | -3.63 | -7.96 | -2.56 | -2.52 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 14 | 14 | 10 | 8 | 6 | 5 |
Shares Outstanding (Diluted) | 14 | 14 | 10 | 8 | 6 | 5 |
Shares Change | 14.41% | 34.34% | 23.90% | 39.27% | 21.18% | 53.27% |
EPS (Basic) | -0.19 | -0.19 | -0.35 | -0.96 | -0.43 | -0.51 |
EPS (Diluted) | -0.19 | -0.19 | -0.35 | -0.96 | -0.43 | -0.51 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.79 | -1.84 | -1.36 | -3.13 | -2.24 | -2.8 |
Free Cash Flow Per Share | -0.13 | -0.13 | -0.13 | -0.38 | -0.38 | -0.57 |
Gross Margin | 88.59% | 81.80% | 82.18% | 81.46% | 87.45% | 85.61% |
Operating Margin | -22.71% | -21.73% | -22.76% | -52.53% | -35.10% | -25.92% |
Profit Margin | -22.36% | -20.70% | -29.75% | -69.38% | -22.26% | -20.73% |
Free Cash Flow Margin | -14.62% | -14.74% | -11.18% | -27.30% | -19.43% | -23.01% |
EBITDA | -1.63 | -1.78 | -1.83 | -2.74 | -3.2 | -2.25 |
EBITDA Margin | -13.33% | -14.24% | -15.00% | -23.86% | -27.80% | -18.52% |
D&A For EBITDA | 1.15 | 0.94 | 0.95 | 3.29 | 0.84 | 0.9 |
EBIT | -2.77 | -2.71 | -2.78 | -6.03 | -4.04 | -3.15 |
EBIT Margin | -22.71% | -21.73% | -22.76% | -52.53% | -35.10% | -25.92% |